| Identification | Back Directory | [Name]
Imiglitazar | [CAS]
250601-04-8 | [Synonyms]
TAK-559
Imiglitazar
Benzenebutanoic acid, γ-[[[4-[(5-methyl-2-phenyl-4-oxazolyl)methoxy]phenyl]methoxy]imino]-, (γE)- | [Molecular Formula]
C28H26N2O5 | [MDL Number]
MFCD16659637 | [MOL File]
250601-04-8.mol | [Molecular Weight]
470.52 |
| Chemical Properties | Back Directory | [Boiling point ]
679.9±65.0 °C(Predicted) | [density ]
1.20±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
4.17±0.10(Predicted) |
| Hazard Information | Back Directory | [Biological Activity]
Imiglitazar (TAK559) is a potent dual agonist of human PPARα and PPARγ1 with EC50 values of 67 and 31 nM. | [target]
| PPARγ1 31 nM (EC 50 ) | PPARα 67 nM (EC 50 ) | | [storage]
Store at -20°C |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|